Açıklama

Treatment duration and dosing analysis across the included probiotic IBS trials. The relationship between intervention length, colony-forming unit dose, and symptom improvement magnitude is explored.

Figure 9

Chart

Source Paper

Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review of Clinical Trials and Multi-Criteria Decision Analysis.

Nutrients (2022)

PMID: 35807868

DOI: 10.3390/nu14132689

Cite This Figure

![Figure 9: Treatment duration and dosing analysis across the included probiotic IBS trials. The relationship between intervention length, colony-forming unit dose, and symptom improvement magnitude is explored.]()

> Source: Cecilia Ceccherini et al. "Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review." *Nutrients*, 2022. PMID: [35807868](https://pubmed.ncbi.nlm.nih.gov/35807868/)

<figure>
  <img src="" alt="Treatment duration and dosing analysis across the included probiotic IBS trials. The relationship between intervention length, colony-forming unit dose, and symptom improvement magnitude is explored." />
  <figcaption>Figure 9. Treatment duration and dosing analysis across the included probiotic IBS trials. The relationship between intervention length, colony-forming unit dose, and symptom improvement magnitude is explored.<br>  Source: Cecilia Ceccherini et al. "Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35807868/">35807868</a></figcaption>
</figure>

İlgili Kanıtlar

Lactobacillus acidophilus için Irritable Bowel Syndrome (IBS)

Derece B · 3 çalışma